No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LRN240816P65000
- 1.75
- -0.23-11.62%
15min DelayClose Jul 23 15:59 ET
1.80High1.75Low
1.80Open1.98Pre Close9 Volume56 Open Interest65.00Strike Price1.62KTurnover59.81%IV9.51%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry1.75Extrinsic Value100Contract SizeAmericanOptions Type-0.2847Delta0.0315Gamma33.69Leverage Ratio-0.0731Theta-0.0132Rho-9.59Eff Leverage0.0611Vega
Intraday
- 5D
- Daily
News
Press Release: Stride Announces Date for Fourth Quarter Fiscal Year 2024 Earnings Call
US Education Market (K-12, Post-Secondary, Corporate Training & Child Care) Report 2024, Featuring Bright Horizons Family Solutions, Stride, Strategic Education, 2U, Grand Canyon Education and Chegg - ResearchAndMarkets.com
Is Stride, Inc.'s (NYSE:LRN) Latest Stock Performance A Reflection Of Its Financial Health?
Strider Bikes to Host the Most Epic Race on 2 Wheels in the Beautiful Black Hills, Rapid City, SD
Indiana Tech-MedCerts Alliance Broadens Educational Pathways for Those Pursuing Careers in Allied Health and IT
Express News | Stride Inc : BMO Raises Target Price to $79 From $73
Comments
Stride's ability to reinvest in the business and generate higher returns on that capital employed is a positive sign. The company's promising trends suggest it's worth further research to see if these trends are likely to persist.
Stride (NYSE:LRN) Shareholders Will Want The ROCE Trajectory To ContinueDespite ownership, insider sales at Stride could worry investors. The lack of purchases and recent large sales suggest insiders don't see current shares as a bargain, possibly indicating less confidence in the company's outlook.
Stride's increasing return on capital and expanding capital base are positive signs for long-term growth. The company's impressive five-year track record warrants further investigation into these trends' sustainability.
The market appears to be less enthusiastic about Stride's stock in recent times, despite its strong historical EPS growth. The current sell-off could present a buying opportunity if fundamental data continues to indicate long-term growth.
$Advanced Health Intelligence(AHI.US$ $Allegiant Travel(ALGT.US$ $BioNexus Gene Lab(BGLC.US$ $BILL Holdings(BILL.US$ $EBET Inc(EBET.US$ $Farfetch(FTCH.US$ $Globant(GLOB.US$ $Hawaiian Electric Industries(HE.US$ $Keysight Technologies(KEYS.US$ $Stride(LRN.US$ $Neptune Wellness Solutions(NEPT.US$ $Ross Stores(ROST.US$ $TE Connectivity(TEL.US$ $TPI Composites(TPIC.US$ $Tremor International(TRMR.US$
2
2
Read more